Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Denali Therapeutics
DNLI
$3.97B
| $1.86M | ﹤0.01% |
23,761
-66,012
| -74% | -$4.08M |
|
2227
Fabrinet
FN
$20.1B
| $1.86M | ﹤0.01% |
19,417
-27,108
| -58% | -$2.43M |
|
|
AAT
2228
American Assets Trust
AAT
$1.4B
| $1.86M | ﹤0.01% |
49,862
-72,279
| -59% | -$2.57M |
|
2229
CareDx
CDNA
$2.42B
| $1.86M | ﹤0.01% |
20,316
-56,992
| -74% | -$4.53M |
|
2230
Global X US Infrastructure Development ETF
PAVE
$15.2B
| $1.85M | ﹤0.01% |
72,037
+60,100
| +503% | +$1.56M |
|
2231
CALL
Stratasys
SSYS
$774M
| $1.85M | ﹤0.01% |
71,600
| – | – |
|
2232
Howard Hughes
HHH
$4.03B
| $1.84M | ﹤0.01% |
19,870
-1,762
| -8% | -$175K |
|
2233
WD-40
WDFC
$3.15B
| $1.84M | ﹤0.01% |
7,191
-10,192
| -59% | -$2.6M |
|
2234
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $1.84M | ﹤0.01% |
+66,731
| New | +$1.83M |
|
2235
Simply Good Foods
SMPL
$982M
| $1.84M | ﹤0.01% |
50,463
-151,844
| -75% | -$5.19M |
|
2236
Graham Holdings Company
GHC
$5.02B
| $1.84M | ﹤0.01% |
2,901
-540
| -16% | -$348K |
|
2237
Skywest
SKYW
$4.34B
| $1.84M | ﹤0.01% |
42,650
-23,009
| -35% | -$1.13M |
|
2238
Ormat Technologies
ORA
$6.65B
| $1.83M | ﹤0.01% |
26,390
-16,376
| -38% | -$1.16M |
|
2239
Quaker Houghton
KWR
$2.92B
| $1.83M | ﹤0.01% |
7,721
-8,859
| -53% | -$2.12M |
|
2240
FB Financial Corp
FBK
$3.04B
| $1.83M | ﹤0.01% |
48,916
-5,095
| -9% | -$211K |
|
2241
PUT
Delta Air Lines
DAL
$60.1B
| $1.82M | ﹤0.01% |
42,100
-80,000
| -66% | -$3.7M |
|
2242
Pacira BioSciences
PCRX
$997M
| $1.82M | ﹤0.01% |
29,964
-25,797
| -46% | -$1.63M |
|
2243
Copa Holdings
CPA
$5.8B
| $1.81M | ﹤0.01% |
24,084
-29,815
| -55% | -$2.4M |
|
|
ZEN
2244
PUT
DELISTED
ZENDESK INC
ZEN
| $1.8M | ﹤0.01% |
12,500
| – | – |
|
2245
Invesco Dorsey Wright Technology Momentum ETF
PTF
$656M
| $1.8M | ﹤0.01% |
+36,207
| New | +$1.7M |
|
2246
PRA Group
PRAA
$755M
| $1.79M | ﹤0.01% |
46,595
-23,922
| -34% | -$919K |
|
2247
American States Water
AWR
$3.46B
| $1.79M | ﹤0.01% |
22,500
-28,532
| -56% | -$2.27M |
|
2248
CALL
BioMarin Pharmaceuticals
BMRN
$12.4B
| $1.79M | ﹤0.01% |
21,400
+9,800
| +84% | +$777K |
|
2249
Four Corners Property Trust
FCPT
$2.75B
| $1.78M | ﹤0.01% |
64,682
-117,667
| -65% | -$3.33M |
|
2250
Southside Bancshares
SBSI
$967M
| $1.78M | ﹤0.01% |
46,716
-4,240
| -8% | -$173K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.